<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39335125</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2072-6694</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>18</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>14</Day></PubDate></JournalIssue><Title>Cancers</Title><ISOAbbreviation>Cancers (Basel)</ISOAbbreviation></Journal><ArticleTitle>Trends in Cancer Incidence and Mortality in US Adolescents and Young Adults, 2016-2021.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3153</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cancers16183153</ELocationID><Abstract><AbstractText>(1) Background: The incidence rate of early onset-cancer (&lt;50) has increased since 1995. Among younger people, cancers in AYAs (aged 15-39 y) are often biologically distinct tumors from those treated in the pediatric and older adult population. The current study describes trends in the United States for the most recent years including the first year of the COVID-19 epidemic. We aimed to describe the recent incidence and mortality trends of cancers in AYAs (aged 15-39 y). (2) Methods: We used data from the Surveillance, Epidemiology, and End Results (SEER 22) from 1 January 2016 to 31 December 2021. Age-adjusted incidence and mortality rates were assessed by SEER*Stat 8.4.3 for major cancer types by sex, race/ethnicity, age, and metropolitan/nonmetropolitan status. Time trends of age-adjusted incidence and mortality rates were examined by sex and metropolitan/nonmetropolitan status. (3) Results: Age-adjusted overall cancer incidence and mortality rates were stable during this study period. The age-adjusted incidence rates declined significantly for ependymoma, melanoma, carcinomas of lung, bronchus, and trachea, unspecified malignant neoplasms, and non-Hodgkin's lymphoma. Significant increases were found for gastrointestinal tract cancers and non-Kaposi sarcomas. The age-adjusted mortality rate decreased for acute myeloid leukemia, melanoma, carcinomas of liver and intrahepatic bile ducts, kidney and, in women, leukemia. For some cancers, rates differed by sex, race, ethnicity, and geography. Monitoring the rates and time trends of AYA cancer emphasizes the distinct health concern for this age group.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Li</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-4953-7012</Identifier><AffiliationInfo><Affiliation>Center for Research on Tobacco and Health, Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA 17033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muscat</LastName><ForeName>Joshua E</ForeName><Initials>JE</Initials><Identifier Source="ORCID">0000-0003-0867-423X</Identifier><AffiliationInfo><Affiliation>Center for Research on Tobacco and Health, Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA 17033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chinchilli</LastName><ForeName>Vernon M</ForeName><Initials>VM</Initials><Identifier Source="ORCID">0000-0001-6488-7809</Identifier><AffiliationInfo><Affiliation>Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA 17033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Behura</LastName><ForeName>Chandrika G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Penn State Children's Hospital, Penn State University College of Medicine, Hershey, PA 17033, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NA</GrantID><Agency>Penn State Children's Hospital Four Diamonds Childhood Cancer Innovation funding</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cancers (Basel)</MedlineTA><NlmUniqueID>101526829</NlmUniqueID><ISSNLinking>2072-6694</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AYAs</Keyword><Keyword MajorTopicYN="N">SEER</Keyword><Keyword MajorTopicYN="N">cancer</Keyword><Keyword MajorTopicYN="N">incidence</Keyword><Keyword MajorTopicYN="N">metropolitan</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">nonmetropolitan</Keyword><Keyword MajorTopicYN="N">race</Keyword><Keyword MajorTopicYN="N">time trends</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. This study was supported by Penn State Children’s Hospital Four Diamonds Childhood Cancer Innovation funding. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39335125</ArticleId><ArticleId IdType="pmc">PMC11430075</ArticleId><ArticleId IdType="doi">10.3390/cancers16183153</ArticleId><ArticleId IdType="pii">cancers16183153</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Koh B., Tan D.J.H., Ng C.H., Fu C.E., Lim W.H., Zeng R.W., Yong J.N., Koh J.H., Syn N., Meng W., et al. Patterns in Cancer Incidence Among People Younger Than 50 Years in the US, 2010 to 2019. JAMA Netw. Open. 2023;6:e2328171. doi: 10.1001/jamanetworkopen.2023.28171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.28171</ArticleId><ArticleId IdType="pmc">PMC10433086</ArticleId><ArticleId IdType="pubmed">37585204</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel R.L., Giaquinto A.N., Jemal A. Cancer statistics, 2024. CA Cancer J. Clin. 2024;74:12–49. doi: 10.3322/caac.21820.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21820</ArticleId><ArticleId IdType="pubmed">38230766</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S., Murtagh S., Han Y., Wan F., Toriola A.T. Breast Cancer Incidence Among US Women Aged 20 to 49 Years by Race, Stage, and Hormone Receptor Status. JAMA Netw. Open. 2024;7:e2353331. doi: 10.1001/jamanetworkopen.2023.53331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.53331</ArticleId><ArticleId IdType="pmc">PMC10818222</ArticleId><ArticleId IdType="pubmed">38277147</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong W., Kim U., Rose J., Hoehn R.S., Kucmanic M., Eom K., Li S., Berger N.A., Koroukian S.M. Geographic Variation and Risk Factor Association of Early Versus Late Onset Colorectal Cancer. Cancers. 2023;15:1006. doi: 10.3390/cancers15041006.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers15041006</ArticleId><ArticleId IdType="pmc">PMC9954005</ArticleId><ArticleId IdType="pubmed">36831350</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J., Xu L., Sun J., Song M., Wang L., Yuan S., Zhu Y., Wan Z., Larsson S.C., Tsilidis K.K., et al. Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019. BMJ Oncol. 2023;2:e000049. doi: 10.1136/bmjonc-2023-000049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjonc-2023-000049</ArticleId></ArticleIdList></Reference><Reference><Citation>Ugai T., Sasamoto N., Lee H.Y., Ando M., Song M., Tamimi R.M., Kawachi I., Campbell P.T., Giovannucci E.L., Weiderpass E., et al. Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nat. Rev. Clin. Oncol. 2022;19:656–673. doi: 10.1038/s41571-022-00672-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41571-022-00672-8</ArticleId><ArticleId IdType="pmc">PMC9509459</ArticleId><ArticleId IdType="pubmed">36068272</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberg P.S., Miranda-Filho A. Cancer Incidence Trends in Successive Social Generations in the US. JAMA Netw. Open. 2024;7:e2415731. doi: 10.1001/jamanetworkopen.2024.15731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2024.15731</ArticleId><ArticleId IdType="pmc">PMC11165384</ArticleId><ArticleId IdType="pubmed">38857048</ArticleId></ArticleIdList></Reference><Reference><Citation>Turgeman I., West H.J. Adolescents and Young Adults with Cancer. JAMA Oncol. 2023;9:440. doi: 10.1001/jamaoncol.2022.6132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoncol.2022.6132</ArticleId><ArticleId IdType="pubmed">36633859</ArticleId></ArticleIdList></Reference><Reference><Citation>Tricoli J.V., Blair D.G., Anders C.K., Bleyer W.A., Boardman L.A., Khan J., Kummar S., Hayes-Lattin B., Hunger S.P., Merchant M., et al. Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma. Cancer. 2016;122:1017–1028. doi: 10.1002/cncr.29871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.29871</ArticleId><ArticleId IdType="pmc">PMC4803597</ArticleId><ArticleId IdType="pubmed">26849082</ArticleId></ArticleIdList></Reference><Reference><Citation>Close A.G., Dreyzin A., Miller K.D., Seynnaeve B.K.N., Rapkin L.B. Adolescent and young adult oncology-past, present, and future. CA Cancer J. Clin. 2019;69:485–496. doi: 10.3322/caac.21585.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21585</ArticleId><ArticleId IdType="pubmed">31594027</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen S.H.M., van der Graaf W.T.A., van der Meer D.J., Manten-Horst E., Husson O. Adolescent and Young Adult (AYA) Cancer Survivorship Practices: An Overview. Cancers. 2021;13:4847. doi: 10.3390/cancers13194847.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13194847</ArticleId><ArticleId IdType="pmc">PMC8508173</ArticleId><ArticleId IdType="pubmed">34638332</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuvers M.J.P., Gedik A., Way K.M., Elbersen-van de Stadt S.M., van der Graaf W.T.A., Husson O. Caring for Adolescents and Young Adults (AYA) with Cancer: A Scoping Review into Caregiver Burdens and Needs. Cancers. 2023;15:3263. doi: 10.3390/cancers15123263.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers15123263</ArticleId><ArticleId IdType="pmc">PMC10297107</ArticleId><ArticleId IdType="pubmed">37370873</ArticleId></ArticleIdList></Reference><Reference><Citation>Armenian S.H., Chao C. Burden of Morbidity and Mortality in Adolescent and Young Adult Cancer Survivors. J. Clin. Oncol. 2024;42:735–742. doi: 10.1200/JCO.23.01751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.23.01751</ArticleId><ArticleId IdType="pubmed">37983585</ArticleId></ArticleIdList></Reference><Reference><Citation>Barr R.D., Ferrari A., Ries L., Whelan J., Bleyer W.A. Cancer in Adolescents and Young Adults: A Narrative Review of the Current Status and a View of the Future. JAMA Pediatr. 2016;170:495–501. doi: 10.1001/jamapediatrics.2015.4689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2015.4689</ArticleId><ArticleId IdType="pubmed">26999630</ArticleId></ArticleIdList></Reference><Reference><Citation>American Cancer Association . Cancer Facts and Figures 2020. ACS; Washington, DC, USA: 2024.</Citation></Reference><Reference><Citation>SEER  Cancer Stat Facts: Cancer among Adolescents and Young Adults (AYAs) (Ages 15–39) 2024.  [(accessed on 21 April 2024)]; Available online:  https://seer.cancer.gov/statfacts/html/aya.html.</Citation></Reference><Reference><Citation>Scott A.R., Stoltzfus K.C., Tchelebi L.T., Trifiletti D.M., Lehrer E.J., Rao P., Bleyer A., Zaorsky N.G. Trends in Cancer Incidence in US Adolescents and Young Adults, 1973–2015. JAMA Netw. Open. 2020;3:e2027738. doi: 10.1001/jamanetworkopen.2020.27738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.27738</ArticleId><ArticleId IdType="pmc">PMC7709088</ArticleId><ArticleId IdType="pubmed">33258907</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X., Yang N.N., Nogueira L., Jiang C., Wagle N.S., Zhao J., Shi K.S., Fan Q., Schafer E., Yabroff K.R., et al. Changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA: A cross-sectional nationwide assessment. Lancet Oncol. 2023;24:855–867. doi: 10.1016/S1470-2045(23)00293-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(23)00293-0</ArticleId><ArticleId IdType="pubmed">37541271</ArticleId></ArticleIdList></Reference><Reference><Citation>National Cancer Institute  About Surveillance, Epidemiology, and End Results Program (SEER) 2023.  [(accessed on 22 April 2024)]; Available online:  https://seer.cancer.gov/about.</Citation></Reference><Reference><Citation>National Cancer Institute  About the SEER Registries 2023.  [(accessed on 19 April 2024)]; Available online:  https://seer.cancer.gov/registries/</Citation></Reference><Reference><Citation>National Cancer Institute  AYA Site Recode 2020 2021.  [(accessed on 21 April 2024)]; Available online:  https://seer.cancer.gov/ayarecode/aya-2020.html.</Citation></Reference><Reference><Citation>National Cancer Institute  Rural Urban Continuum Codes, 2013 2014.  [(accessed on 4 April 2024)]; Available online:  https://seer.cancer.gov/seerstat/variables/countyattribs/ruralurban.html.</Citation></Reference><Reference><Citation>Economic Research Service  . Rural-Urban Continuum Codes. United States Department of Agriculture; Washington, DC, USA: 2024.  [(accessed on 3 April 2024)].  Available online:  https://www.ers.usda.gov/data-products/rural-urban-continuum-codes/</Citation></Reference><Reference><Citation>US Department of Agriculture . Rural America at a Glance 2019 Edition. USDA; Washington, DC, USA: 2019.</Citation></Reference><Reference><Citation>National Cancer Institute  Surveillance Research Program, National Cancer Institute SEER*Stat Software Version 8.4.3.  [(accessed on 18 April 2024)];2024  Available online:  https://seer.cancer.gov/seerstat/</Citation></Reference><Reference><Citation>National Cancer Institute  Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: Incidence—SEER Research Limited-Field Data, 22 Registries, Nov 2023 Sub (2000–2021)—Linked to County Attributes—Time Dependent (1990–2022) Income/Rurality, 1969–2022 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Released April 2024, Based on the November 2023 Submission.  [(accessed on 18 April 2024)];2022  Available online:  https://seer.cancer.gov/data.</Citation></Reference><Reference><Citation>National Cancer Institute  Incidence-Based Mortality 2021.  [(accessed on 21 December 2023)]; Available online:  https://surveillance.cancer.gov/statistics/ibm/</Citation></Reference><Reference><Citation>National Cancer Institute  Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: Incidence-Based Mortality—SEER Research Limited-Field Data, 22 Registries (excl IL and MA), Nov 2023 Sub (2000–2021)—Linked to County Attributes—Time Dependent (1990–2022) Income/Rurality, 1969–2022 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Released April 2024, Based on the November 2023 Submission.  [(accessed on 21 April 2024)];2022  Available online:  www.seer.cancer.gov/mortality.</Citation></Reference><Reference><Citation>Lim H., Devesa S.S., Sosa J.A., Check D., Kitahara C.M. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974–2013. JAMA. 2017;317:1338–1348. doi: 10.1001/jama.2017.2719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.2719</ArticleId><ArticleId IdType="pmc">PMC8216772</ArticleId><ArticleId IdType="pubmed">28362912</ArticleId></ArticleIdList></Reference><Reference><Citation>van Der Meer D.J., Karim-Kos H.E., van Der Mark M., Aben K.K., Bijlsma R.M., Rijneveld A.W., van Der Graaf W.T., Husson O. Incidence, Survival, and Mortality Trends of Cancers Diagnosed in Adolescents and Young Adults (15–39 Years): A Population-Based Study in The Netherlands 1990–2016. Cancers. 2020;12:3421. doi: 10.3390/cancers12113421.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers12113421</ArticleId><ArticleId IdType="pmc">PMC7698904</ArticleId><ArticleId IdType="pubmed">33218178</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S., Harper A., Ruan Y., Barr R., Frazier A.L., Ferlay J., Steliarova-Foucher E., Fidler-Benaoudia M.M. International Trends in the Incidence of Cancer Among Adolescents and Young Adults. J. Natl. Cancer Inst. 2020;112:1105–1117. doi: 10.1093/jnci/djaa007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/djaa007</ArticleId><ArticleId IdType="pmc">PMC7669231</ArticleId><ArticleId IdType="pubmed">32016323</ArticleId></ArticleIdList></Reference><Reference><Citation>Jemal A., Miller K.D., Ma J., Siegel R.L., Fedewa S.A., Islami F., Devesa S.S., Thun M.J. Higher Lung Cancer Incidence in Young Women Than Young Men in the United States. N. Engl. J. Med. 2018;378:1999–2009. doi: 10.1056/NEJMoa1715907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1715907</ArticleId><ArticleId IdType="pmc">PMC7717174</ArticleId><ArticleId IdType="pubmed">29791813</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunderland E.M., Hu X.C., Dassuncao C., Tokranov A.K., Wagner C.C., Allen J.G. A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects. J. Expo. Sci. Environ. Epidemiol. 2019;29:131–147. doi: 10.1038/s41370-018-0094-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41370-018-0094-1</ArticleId><ArticleId IdType="pmc">PMC6380916</ArticleId><ArticleId IdType="pubmed">30470793</ArticleId></ArticleIdList></Reference><Reference><Citation>Faja F., Esteves S., Pallotti F., Cicolani G., Di Chiano S., Delli Paoli E., Lenzi A., Lombardo F., Paoli D. Environmental disruptors and testicular cancer. Endocrine. 2022;78:429–435. doi: 10.1007/s12020-022-03171-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-022-03171-z</ArticleId><ArticleId IdType="pmc">PMC9637059</ArticleId><ArticleId IdType="pubmed">36036879</ArticleId></ArticleIdList></Reference><Reference><Citation>Pluta J., Pyle L.C., Nead K.T., Wilf R., Li M., Mitra N., Weathers B., D’Andrea K., Almstrup K., Anson-Cartwright L., et al. Identification of 22 susceptibility loci associated with testicular germ cell tumors. Nat. Commun. 2021;12:4487. doi: 10.1038/s41467-021-24334-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24334-y</ArticleId><ArticleId IdType="pmc">PMC8302763</ArticleId><ArticleId IdType="pubmed">34301922</ArticleId></ArticleIdList></Reference><Reference><Citation>McGlynn K.A., Cook M.B. Etiologic factors in testicular germ-cell tumors. Future Oncol. 2009;5:1389–1402. doi: 10.2217/fon.09.116.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fon.09.116</ArticleId><ArticleId IdType="pmc">PMC3000220</ArticleId><ArticleId IdType="pubmed">19903067</ArticleId></ArticleIdList></Reference><Reference><Citation>Franchini F., Palatucci G., Colao A., Ungaro P., Macchia P.E., Nettore I.C. Obesity and Thyroid Cancer Risk: An Update. Int. J. Environ. Res. Public Health. 2022;19:1116. doi: 10.3390/ijerph19031116.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19031116</ArticleId><ArticleId IdType="pmc">PMC8834607</ArticleId><ArticleId IdType="pubmed">35162142</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson K.M., Cho E. Obesity and Kidney Cancer. Recent. Results Cancer Res. 2016;208:81–93. doi: 10.1007/978-3-319-42542-9_5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-42542-9_5</ArticleId><ArticleId IdType="pubmed">27909903</ArticleId></ArticleIdList></Reference><Reference><Citation>Bibbins-Domingo K., Grossman D.C., Curry S.J., Barry M.J., Davidson K.W., Doubeni C.A., Epling J.W., Kemper A.R., Krist A.H., Kurth A.E., et al. Screening for Thyroid Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2017;317:1882–1887. doi: 10.1001/jama.2017.4011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.4011</ArticleId><ArticleId IdType="pubmed">28492905</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Langevin A.M., Houghton P.J., Zheng S. Genomic disparities between cancers in adolescent and young adults and in older adults. Nat. Commun. 2022;13:7223. doi: 10.1038/s41467-022-34959-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34959-2</ArticleId><ArticleId IdType="pmc">PMC9700745</ArticleId><ArticleId IdType="pubmed">36433963</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitra D., Luo X., Morgan A., Wang J., Hoang M.P., Lo J., Guerrero C.R., Lennerz J.K., Mihm M.C., Wargo J.A., et al. An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background. Nature. 2012;491:449–453. doi: 10.1038/nature11624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11624</ArticleId><ArticleId IdType="pmc">PMC3521494</ArticleId><ArticleId IdType="pubmed">23123854</ArticleId></ArticleIdList></Reference><Reference><Citation>Challapalli S.D., Shetty K.R., Bui Q., Osazuwa-Peters N., Adjei Boakye E. Sun protective behaviors among adolescents and young adults in the United States. J. Natl. Med. Assoc. 2023;115:353–361. doi: 10.1016/j.jnma.2023.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnma.2023.04.002</ArticleId><ArticleId IdType="pubmed">37142483</ArticleId></ArticleIdList></Reference><Reference><Citation>Center for Disease Control and Prevention  HIV Declines among Young People and Drives Overall Decrease in New HIV Infections.  [(accessed on 23 May 2023)]; Available online:  https://www.cdc.gov/media/releases/2023/p0523-hiv-declines-among-young-people.html.</Citation></Reference><Reference><Citation>London J.W., Fazio-Eynullayeva E., Palchuk M.B., Sankey P., McNair C. Effects of the COVID-19 Pandemic on Cancer-Related Patient Encounters. JCO Clin. Cancer Inform. 2020;4:657–665. doi: 10.1200/CCI.20.00068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/CCI.20.00068</ArticleId><ArticleId IdType="pmc">PMC7444638</ArticleId><ArticleId IdType="pubmed">32716647</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahnd W.E., James A.S., Jenkins W.D., Izadi S.R., Fogleman A.J., Steward D.E., Colditz G.A., Brard L. Rural–Urban Differences in Cancer Incidence and Trends in the United States. Cancer Epidemiol. Biomark. Prev. 2018;27:1265–1274. doi: 10.1158/1055-9965.EPI-17-0430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1055-9965.EPI-17-0430</ArticleId><ArticleId IdType="pmc">PMC5787045</ArticleId><ArticleId IdType="pubmed">28751476</ArticleId></ArticleIdList></Reference><Reference><Citation>McDow A.D., Zahnd W.E., Angelos P., Mellinger J.D., Ganai S. Impact of Rurality on National Trends in Thyroid Cancer Incidence and Long-Term Survival. J. Rural. Health. 2020;36:326–333. doi: 10.1111/jrh.12374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jrh.12374</ArticleId><ArticleId IdType="pubmed">31099945</ArticleId></ArticleIdList></Reference><Reference><Citation>Regmi S., Farazi P.A., Lyden E., Kotwal A., Ganti A.K., Goldner W. Disparities in Thyroid Cancer Diagnosis Based on Residence and Distance from Medical Facility. J. Endocr. Soc. 2024;8:bvae033. doi: 10.1210/jendso/bvae033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jendso/bvae033</ArticleId><ArticleId IdType="pmc">PMC10928505</ArticleId><ArticleId IdType="pubmed">38481601</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlton M., Schlichting J., Chioreso C., Ward M., Vikas P. Challenges of Rural Cancer Care in the United States. Oncology. 2015;29:633–640.</Citation><ArticleIdList><ArticleId IdType="pubmed">26384798</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis D.R., Siembida E.J., Seibel N.L., Smith A.W., Mariotto A.B. Survival outcomes for cancer types with the highest death rates for adolescents and young adults, 1975–2016. Cancer. 2021;127:4277–4286. doi: 10.1002/cncr.33793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.33793</ArticleId><ArticleId IdType="pubmed">34308557</ArticleId></ArticleIdList></Reference><Reference><Citation>Berk-Krauss J., Stein J.A., Weber J., Polsky D., Geller A.C. New Systematic Therapies and Trends in Cutaneous Melanoma Deaths Among US Whites, 1986–2016. Am. J. Public Health. 2020;110:731–733. doi: 10.2105/AJPH.2020.305567.</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.2020.305567</ArticleId><ArticleId IdType="pmc">PMC7144422</ArticleId><ArticleId IdType="pubmed">32191523</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhansali R.S., Pratz K.W., Lai C. Recent advances in targeted therapies in acute myeloid leukemia. J. Hematol. Oncol. 2023;16:29. doi: 10.1186/s13045-023-01424-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-023-01424-6</ArticleId><ArticleId IdType="pmc">PMC10039574</ArticleId><ArticleId IdType="pubmed">36966300</ArticleId></ArticleIdList></Reference><Reference><Citation>Prescott K., Jacobs M., Stock W., Wynne J. New Approaches to Treating Challenging Subtypes of ALL in AYA Patients. Curr. Hematol. Malig. Rep. 2020;15:424–435. doi: 10.1007/s11899-020-00597-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11899-020-00597-y</ArticleId><ArticleId IdType="pmc">PMC8279222</ArticleId><ArticleId IdType="pubmed">32920736</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>